Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Solana Company (NASDAQ:HSDT) Reports Q3 Net Income of USD 105.2 Million and Staking Revenue of USD 3.3 Million

Management said it reportedNet Incomefor the third quarter of USD 105.2 million. Revenue of USD 3.4 million consisted of USD 3.3 million of staking revenue, which includes rewards on its treasury and revenue from third party stake, and USD 23,000 of other revenue. Staking …

Nitish Kishor | 12 November 2026

Humacyte (NASDAQ:HUMA) Q3 Earnings Beat: Loss of USD 0.06 Per Share as Symvess Sales Reach USD 1.0 Million

Net loss was USD 15.5 million for the quarter, against USD 17.5 million in the third quarter of 2025. For the nine months, net loss was USD 70.0 million, against USD 16.0 million, a sharp increase from the prior-year nine-month figure. The accumulatedDeficitwas USD …

Nitish Kishor | 12 November 2026

Hyliion Holdings (NYSE American:HYLN) Raises 2026 Revenue Outlook to USD 18 Million After Q3 Revenue of USD 7.5 Million

Management said revenue came in well ahead of its outlook of just under USD 5 million, primarily reflecting accelerating progress on the 800 kilowatt power module for the Office of Naval Research and the availability of USD 3 million of additional funding under the …

Nitish Kishor | 12 November 2026

iBio (NASDAQ:IBIO) Fiscal Q1 2027 Loss of USD 0.05 Per Share Is Narrower Than Estimate as Revenue Reaches USD 1.1 Million

Net loss was USD 7.6 million, or USD 0.05 per share, against a net loss of about USD 5.7 million, or USD 0.11 per share, for the three months ended September 30, 2025. The company's fiscal year ends June 30, so the quarter is …

Nitish Kishor | 12 November 2026

SeaStar Medical (NASDAQ:ICU) Q3 Product Revenue Rises 247% to USD 635,000 as Loss Widens to USD 1.03 Per Share

Management said net revenue reflected increasedDemandfor its pediatric device, a 247% increase from approximately USD 183,000 in the third quarter of 2025. Nine month net revenue more than doubled to USD 1.7 million, which management said puts it in a position to exceed its …

Nitish Kishor | 12 November 2026

Inhibikase Therapeutics (NASDAQ:IKT) Q3 Loss of USD 0.10 Per Share Is Narrower Than Estimate as Phase 3 Spending Rises

For the nine months, net loss was USD 56.4 million against USD 35.5 million, and loss per share was USD 0.31 against USD 0.40. Cash and cash equivalents were USD 51.7 million at September 30, alongside marketable securities that the filing reports separately. Cash …

Nitish Kishor | 12 November 2026

Is Terrestrial Energy (NASDAQ:IMSR) Delivering on Its 2026 Regulatory Guidance?

The company held USD 276.3 million in cash, cash equivalents and short-term investments at quarter end, compared with USD 283.4 million at the end of the second quarter. Cash burn for the quarter was USD 7.1 million, or about USD 2.4 million per month, …

Nitish Kishor | 12 November 2026

Intelligent Bio Solutions (NASDAQ:INBS) Fiscal Q1 Loss of USD 0.86 Per Share Narrower Than Estimate as Revenue Rises 25%

Gross profit increased USD 239,713 to USD 758,004 from USD 518,291. Cost of revenue rose USD 40,325 to USD 633,831, which the company attributed to directManufacturinglabor costs from added factory hiring in the United Kingdom and higher direct overhead.

Nitish Kishor | 12 November 2026

MiNK Therapeutics (NASDAQ:INKT) Reports First Product Revenue and a Q3 Loss of USD 0.50 Per Share

Management said it recognized its first pre-commercial product revenue, from its lead cell therapy candidate supplied on a paid per patient basis under a named patient import pathway, in collaboration with two partners and open in multiple countries outside the United States. Management said …

Nitish Kishor | 12 November 2026

Inovio Pharmaceuticals (NASDAQ:INO) Q3 Loss of USD 0.50 Per Share Is Wider Than Estimate After FDA Approval of VOCERYQ

Management said the increase in net loss was primarily driven by a USD 26.9 million non-cash loss on theFair Valueof warrant liabilities, compared with a USD 22.5 million non-cash loss a year earlier. Nine-month net loss was USD 74.9 million against USD 88.7 million.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…